共 117 条
[1]
Scheltens P(2021)Alzheimer's disease The Lancet. 397 1577-1590
[2]
De Strooper B(2011)The role of beta-amyloid peptide in neurodegenerative diseases Ageing Res Rev. 10 440-452
[3]
Kivipelto M(2022)Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review Neurochem Int. 153 3021-3032
[4]
Holstege H(2018)Synaptic dysfunction in Alzheimer's disease: abeta, tau, and epigenetic alterations Mol Neurobiol. 55 181-190
[5]
Chételat G(2018)Biomarkers for Alzheimer disease: classical and novel candidates' review Neuroscience. 370 1666-1674
[6]
Teunissen CE(2022)Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease Neural Regen Res. 17 543-549
[7]
Maltsev AV(2022)Pathological mechanisms and therapeutic strategies for Alzheimer's disease Neural Regen Res. 17 1833-1863
[8]
Bystryak S(2019)Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis Cell Mol Life Sci. 76 17-32
[9]
Galzitskaya OV(2015)The role of visinin-like protein-1 in the pathophysiology of Alzheimer's disease J Alzheimers Dis. 47 7331-7339
[10]
Cecerska-Heryc E(2002)Reversible translocation and activity-dependent localization of the calcium-myristoyl switch protein VILIP-1 to different membrane compartments in living hippocampal neurons J Neurosci. 22 20-778